LV-TRE-VP64 human MyoD-T2A-dsRedExpress2 Citations (4)

Originally described in: Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain.
Kabadi AM, Thakore PI, Vockely CM, Ousterout DG, Gibson TM, Guilak F, Reddy TE, Gersbach CA ACS Synth Biol. 2014 Dec 10. PubMed Journal

---

Articles Citing LV-TRE-VP64 human MyoD-T2A-dsRedExpress2

Articles
CRISPR/Cas9-generated mouse model of Duchenne muscular dystrophy recapitulating a newly identified large 430 kb deletion in the human DMD gene. Egorova TV, Zotova ED, Reshetov DA, Polikarpova AV, Vassilieva SG, Vlodavets DV, Gavrilov AA, Ulianov SV, Buchman VL, Deykin AV. Dis Model Mech. 2019 Apr 25;12(4). pii: 12/4/dmm037655. doi: 10.1242/dmm.037655. PubMed
Functional skeletal muscle constructs from transdifferentiated human fibroblasts. Xu B, Siehr A, Shen W. Sci Rep. 2020 Dec 16;10(1):22047. doi: 10.1038/s41598-020-78987-8. PubMed
4-Phenylbutyrate restores localization and membrane repair to human dysferlin mutations. Tominaga K, Tominaga N, Williams EO, Rufibach L, Schowel V, Spuler S, Viswanathan M, Guarente LP. iScience. 2021 Dec 20;25(1):103667. doi: 10.1016/j.isci.2021.103667. eCollection 2022 Jan 21. PubMed
Bitter taste receptor (TAS2R) 46 in human skeletal muscle: expression and activity. Talmon M, Massara E, Quaregna M, De Battisti M, Boccafoschi F, Lecchi G, Puppo F, Bettega Cajandab MA, Salamone S, Bovio E, Boldorini R, Riva B, Pollastro F, Fresu LG. Front Pharmacol. 2023 Sep 12;14:1205651. doi: 10.3389/fphar.2023.1205651. eCollection 2023. PubMed

If you have published an article using this material, please email us at to have your article added to this page.